Background: Inflammatory bowel disease [IBD] results particularly from an aberrance of CD4 + helper and regulatory T cells and comprises histopathologically chronic active enterocolitis with features reflecting both activity and chronicity of mucosal inflammation. The exact immunologicalhistological correlation in IBD is not understood. Methods: We studied the correlation between colonic mucosal CD4 + T cell subsets [Th1, Th2, Th17, Th22 and Treg] and mucosal histological changes in ulcerative colitis [UC] and Crohn's disease [CD]. CD4 + T cell subtyping and enumeration were achieved by flow cytometry. Histological features were categorized and assessed semi-quantitatively using three validated histological scoring schemes [ECAP, RHI and D'Haens]. Correlations between prevalence [%] of CD4 + T cell subsets and histological scores were analysed. Results: Treg cells were correlated with ECAP category A [activity] as well as RHI scores. Treg cell were increased particularly in mucosa with severe neutrophilic infiltration in the cryptal/ surface epithelium and in lamina propria, and with basal plasmacytosis. Th17 cells were also increased in cases with extensive neutrophil infiltrate in lamina propria, whereas RORc + cells were increased in cases with severe lymphoplasmacytic infiltration in lamina propria. In both UC and CD, mucosa with marked crypt architectural alteration had increased IL-22 + and Th22 cells. UC with Paneth cell metaplasia had higher Th17 cells. CD with granuloma had increased IL-22 + and IL-22 + IFN-γ + cells.
Introduction
The histopathology of inflammatory bowel disease [IBD] , ulcerative colitis [UC] and Crohn's disease [CD] , comprises a chronic active inflammation of the intestinal mucosa [enterocolitis] , with shared and distinctive features. From the biological perspective and for the purpose of practical clinical-histopathological assessment, the various histological changes in IBD are broadly categorized into 'activity' and 'chronicity'. Activity is characterized by active/acute inflammation, i.e. neutrophil infiltration, of the glandular/cryptal epithelium [cryptitis and crypt abscess] and surface epithelium [erosion and ulceration], usually causing destructive damage of the epithelium, along with mixed neutrophilic and lymphoplasmacytic [mononuclear cell] infiltration in lamina propria with the latter tending to persist [and thus be regarded as chronic inflammation]. Chronicity is primarily the subsequent histoarchitectural and cytological alterations of glands secondary to epithelial injury following a prolonged and repetitive active and chronic inflammation, and its main characteristics are cryptal architectural alteration/distortion [including disorganized arrangement, variable shape and size, shortening/dropout and branching of crypts], along with villiform configuration of the surface epithelium as well as Paneth cell metaplasia [in left colon] and/or Paneth cell hyperplasia [in right colon and/or terminal ileum]. However, none of these features is pathognomonic per se for IBD.
The key pathogenetic mechanism of IBD is the aberrant immunity of bowel mucosa, including both innate immunity and adaptive immunity, with the involvement of gut microbiota and defects in the gut barrier. Aberrant adaptive immunity is primarily mediated by T cells, with fundamental defects of CD4 + 
helper T [Th] cells and regulatory T [Treg] cells. Treg cells and different Th cell subsets,
including Th1, Th2, Th17 and Th22, defined by their production of lineage-specific cytokines and functions, play a discriminatory role in translating certain antigen-specific immune responses into different tissue functions or pathology. In general, Th1 and Th2 cells are primarily pro-inflammatory effectors, while Treg cells help to maintain balance between inflammation and tolerance, 1, 2 Th17 cells have both pro-inflammatory and protective effects, whereas Th22 cells play a role in epithelial regeneration and repairing. 3 All of these CD4 + T cells also interact with each other. It is reasonable to suggest that the different histological patterns of mucosal inflammation and associated histomorphological alterations of glandular epithelium in IBD may be associated with different immunological mechanisms that involve different subsets/patterns of immune cells and cytokines. However, the exact histological-immunological correlation in IBD is not yet clear and has not been specifically studied. This study aims to explore the association between the key histopathological features of the activity and chronicity in IBD and the prevalence of CD4 + T cell subsets in lamina propria, to further understand the pathological basis of IBD and understand the pattern of histological improvement in response to different targeted therapies in future studies. This requires histopathological scoring that reflects both activity and chronicity as well as lamina propria T lymphocyte immunophenotyping.
Material and Methods

Patient cohort and colonic mucosal tissue samples
In total, 53 patients with IBD [27 UC, 26 CD] were enrolled into the study from the University of Calgary IBD Clinic. For CD cases, only those with colonic involvement [i.e. Crohn's colitis or ileocolitis] were included and only colonic mucosal tissues were studied, given that there are differences between ileal and colonic mucosal immunity. The diagnoses and classification of UC or CD were made by specialized IBD clinicians [SG, MI] based on overall clinical, radiographic, endoscopic and histological findings, according to widely accepted criteria. 4 The patients' data were extracted from their medical records and included demographic characteristics, extent of disease, endoscopic features, clinical and endoscopic assessments of disease activity, and medication use [ Table 1 ].
The clinical disease activities of the patients' symptoms were assessed using the total Mayo score for UC 5 and Harvey-Bradshaw 
Histopathological assessment
Colonic mucosal biopsies were taken from areas with visibly inflamed mucosa on endoscopy [for the majority of patients] or taken randomly when there was no visible inflammation, where the endoscopic scoring of disease activity was made. All endoscopic scoring and biopsies were made/taken by an expert IBD endoscopist [MI] . Histopathological changes seen in the biopsies were carefully evaluated on routine haematoxylin and eosin [H&E]-stained slides, with all features being categorized and assessed semi-quantitatively independently by a gastrointestinal pathologist [XG] , who was blinded to the clinical and endoscopic findings, using a newly developed [by XG] comprehensive histological scoring system built based on a modification of several published schemes. [9] [10] [11] [12] [13] [14] This system reflects all common histological features of both active and chronic inflammation seen in IBD. The grading/scoring scheme, coined ECAP [Extent, Chronicity, Activity and Plus] system, [15] [16] [17] Table 2 , including the specific criteria for inclusion into each of these grades. Examples of the key histological features are displayed in Figure 1 .
The ECAP system has been successfully used by us in studies involving assessment of UC disease activity and severity, in which the ECAP scores showed good concordance with high-definition endoscopic findings and sensitivity in detecting minor histological abnormalities in apparently normal mucosa. 15 As a comparison and for further confirmation, two other wellknown and widely accepted histological grading systems for IBD 
Immunological profiling of CD4 + T lymphocyte subsets in colonic lamina propria
Profiling and enumeration of the subsets of CD4 + T lymphocytes in colonic mucosa were achieved by multicolour flow cytometry. Using fresh tissue samples of colonic mucosa from the same biopsies [taken from the same area and at the same time in the same colonoscopy procedure] that were sent to the pathology laboratory for histological evaluation, lamina propria mononuclear cells [LPMNCs] were isolated as previously described. 20 Briefly, the epithelial cells were removed by agitated incubations with Ca 2+ -and Mg 2+ -free Hanks' balanced salt solution [HBSS, Life Technologies] containing 1 mM EDTA [Sigma-Aldrich] at 37°C. The tissues were then incubated in RPMI1640 cell culture media with l-glutamine containing 2.5% fetal bovine serum, 1 mM dithiothreitol, 100 U/ ml penicillin and 100 μg/ml streptomycin, and later incubated in The different distinct CD4 + T cell subsets were defined by their expression of specific cytokines and master transcription factors: [ 20 and as exemplified in Figure 2 . The flow cytometry data were initially treated blindly from all clinical-endoscopic-histological diagnoses.
Statistical analysis
Continuous variables are shown as the mean [±SD] . The probability of significant difference between two groups was calculated using the 
Results
Correlation between ECAP and RHI and between ECAP and D'Haens in histological scoring
In the same group of UC cases, an excellent in-parallel correlation was shown between the total ECAP score and RHI score [γ = 0.893, p < 0.001] as well as between ECAP category A score and RHI score [γ = 0.955, p < 0.001] [ Figure 3 ]. ECAP category C score was not compared with RHI score, as the latter only represents the activity.
In the same group of CD patients, an equally good correlation was demonstrated between total ECAP score and D'Haens score 
Association between histological and clinical-endoscopic assessments of disease activity
Based on total Mayo clinical disease activity scores [which include endoscopy], UC cases were categorized into three groups for further analysis. As compared with those in remission, patients with moderate to severe activity showed significantly higher total ECAP scores [p < 0.05] and category A scores [p < 0.01].
A similar relationship was also found between ECAP scores and Mayo endoscopic subscores: patients with Mayo endoscopic score 3 had significantly higher total ECAP scores [p < 0.05] as well as higher category A scores [p < 0.01] in their colonic biopsies, as compared with those in the Mayo endoscopic score 0-1 group.
However, there was no significant correlation between the clinical or endoscopic severity of disease activity and the ECAP category C and category P scores in UC [data not shown]. This suggests that the commonly used total Mayo score and Mayo endoscopic subscore essentially reflect the histological activity but not the chronicity of UC.
In CD patients, there was no significant correlation between total ECAP or any subcategory scores and either Harvey-Bradshaw disease activity index or SES-CD scores. In agreement with the ECAP scoring, CD D'Haens histology scores also failed to show a correlation with the clinical and endoscopic scores in the same cases. . 28 Our present study specifically and systemically correlates the histopathological features of IBD with the lamina propria CD4 + T cell subsets, and some interesting observations were made regarding the histological-immunological association. Among the CD4 + T cells in mucosal lamina propria the Treg cells appeared to be positively associated with the increasing severity of active inflammation [i.e. neutrophilic inflammation] in both UC and CD patients. Th22 and Th17 cells appeared to be associated with the features of chronicity, with Th22 correlating with crypt architecture alteration and Th17 with Paneth cell metaplasia/ hyperplasia. Furthermore, IL-22 + Th cells seemed to be associated with the occurrence of epithelioid granuloma in CD patients.
Discussion
Our novel histological scoring scheme, the ECAP system, was designed to fully reflect almost all components of the histopathology of IBD, including both active inflammation and chronic histocytological changes. This approach has been proven in several of our studies to be concordant with the best endoscopic technology in assessment of the mucosal inflammation and mucosal healing in UC. [15] [16] [17] Although it has not been widely validated, a preliminary validation process has shown excellent inter-observer agreement. The parameters included in category A contain all elements of the recently proposed and validated RHI, 18 and can be easily converted to RHI. Our ECAP total scores and subcategory A scores were found to be in excellent correlation with RHI, as shown in this and other studies. 17 Additionally, the ECAP scores, including the subcategory A and C scores, are found to be in parallel to the D'Haens score in our study. The reliability and usefulness of our ECAP system was again proven. However, for CD cases the ECAP scores failed to show good concordance with the currently used clinical and endoscopic scoring schemes, as did the D'Haens score. The reasons for this may include the characteristic patchiness and focal and transmural nature of inflammation in CD, and the currently used HBI and SES-CD for assessment of CD may not be sensitive or reliable as the histological standard. Previous studies, using several different histological indices, also failed to demonstrate a histological correlation with clinically or endoscopically assessed disease activity in CD. [29] [30] [31] Nevertheless, we believe that the ECAP system still provides a reasonable method to semi-quantitatively assess the major changes and the degree of mucosal inflammation in CD at the histological level.
Treg cells are crucial for the homeostasis of normal gut mucosal immunity. In active UC and CD, they are abundantly recruited to lamina propria and, in contrast, depleted in peripheral circulation. The pivotal role of Treg cells in the control of pro-inflammatory effects of effector T cells was found to be maintained in the setting of IBD, whereas their protective function was compromised due to the gain of a pro-inflammatory effect in IL-17 + FoxP3 + CD4 + T cells under certain cytokine environments, 32 as it is well known that Treg cells under certain inflammatory conditions can lose suppressive function and acquire pathogenicity. 33 We previously demonstrated an abundance of the crossover population of Th17/Treg cells in peripheral or lamina propria compartments in IBD patients. 24 Others found that the abundance of Treg cells in the mucosa in active UC was consistent with the disease activity assessed clinically and endoscopically, and it could be modulated by use of immunosuppressive medications and biological agents. 1, [34] [35] [36] In this study, we further demonstrated that the Treg cells were closely associated with overall histological abnormalities in IBD, primarily active inflammation [i.e. neutrophil infiltration in glandular epithelium and lamina propria]. Our study was not large enough to explore differences due to different drugs and this will require longitudinal studies which are ongoing. Th17 cells are mainly responsible for production of IL-17A, which is known to exert dual effects in IBD, as a pro-inflammatory cytokine as well as a protective factor in mucosal healing. Th17 and its cytokines IL-17A, IL-21 and IL-22 were increased in the involved gut mucosa in active IBD, and their increase was correlated with disease activity assessed clinically-endoscopically. 37 Moreover, T17 plasticity, particularly along the Th1-Th17 and Th17-Treg axes, plays an important role in the pathogenesis of IBD. 38 In the current study, Th17 cells were found to be associated with lymphoplasmacytic infiltration in lamina propria in UC, one of the key histopathological features of + T cells in colonic lamina propria in UC. 27 We have also reported previously that IL-22
+ T cells and Th22 cells decreased in UC. 20 IL-22 also plays a crucial role in maintaining the epithelium integrity of mucosa and skin, while participating in inflammation, 3 as its receptor is expressed only in epithelial cells. 40 IL-22 and activation of its downstream transcription factor STAT3 [IL-22/STAT3 signalling] were found to be two important mediators of intestinal epithelial host defence and wound healing during mucosal inflammation, which could induce the proliferation and reconstitution of mucosal epithelial cells, enhance goblet cells to regenerate and produce mucusassociated proteins, promote the remodelling of extracellular matrix and cell migration, and stimulate the production of antimicrobial peptides. 41, 42 Some investigators have even proposed IL-22/STAT3 signalling as a potential therapeutic approach in promoting mucosal healing in IBD. 43 In addition, a recent study found that human microbe-responsive γδ T cells can polarize colonic CD4 + T cells to become IL-22 + cells, an thus promote IL-22 production and IL-22 inducible antimicrobial protein calprotectin secretion, as a mechanism of promoting mucosal barrier defence. 44 In this study we observed that alternation of crypt architecture, a key feature of chronicity as well as a reflection of glandular/cryptal epithelium restitution/regeneration, was associated with IL-22 +
CD4
+ T cells and Th22 cells. From the biological perspective, our finding may reflect the role of IL-22 and Th22 cells in bowel epithelial regeneration and mucosal healing.
Paneth cells are unique specialized secretory epithelial cells known to play an important role in the innate host defence in normal intestinal mucosa through their secretion of antimicrobial peptides and proteins, e.g. α-defensins. Paneth cell metaplasia, defined as the aberrant presence of any number of Paneth cells in the distal colon [descending colon, sigmoid and rectum], is also a histological indicator of chronic mucosal injury, particularly chronicity of IBD. Paneth cell hyperplasia [abnormally prominent, enlarged, in aggregates, and with prominent degranulation] in the proximal colon and terminal ileum seems to have the same significance in the setting of IBD, 41, 45 and it was frequently regarded as being equivalent to, and was grouped together with, Paneth cell metaplasia, [45] [46] [47] given their comparable biological significance, although in the strict sense this is inaccurate. Paneth cell metaplasia/hyperplasia was found to be positively associated with crypt distortion and lymphoplasmacytic infiltration in lamina propria and related to epithelial regeneration and repair. 45, 48 Here we noted that UC patients with Paneth cell metaplasia had a significantly higher number of Th17 cells in colonic mucosa as compared with those without Paneth cell metaplasia. To our knowledge, the association or interaction between Paneth cells or Paneth cell metaplasia/hyperplasia and the adaptive immunity of gut mucosa is little known. Kamal et al. reported an increase I n Paneth cell abundance in the small bowel of Trichinella spiralis-infected mice, as a feature of innate mucosal defence, and the increase was modulated by a thymic-independent population of mucosal T cells. IFN-γ in the intraepithelial lymphocytes and Paneth cell defensins in the duodenal mucosa in coeliac disease. 50 Recent studies also suggested a link between Paneth cells and Th17 cells. Salzman found in mice that the expression of human defensin [HD]-5 in small intestine resulted in a reduction of Th17 cell number in lamina propria following the loss of segmented filamentous bacteria, suggesting that Paneth cell defensins can regulate the acquired immune responses through regulating the commensal microbiome. 51, 52 On the other hand, Th17 cells in lamina propria were found to induce mucosal antimicrobial peptide expression, notably RegIIIγ, via IL-22 secretion. 53, 54 Moreover, Paneth cells per se can produce IL-17 in response to TNF challenge. 55 Based on all of these findings, it is our hypothesis that the association of Th17 cells with Paneth cell metaplasia found here may be explained by disruption of the intestinal microbiota, which occurs in IBD, that induce Paneth cell metaplasia and at the same time lead to the increase of Th17 cells in lamina propria.
The presence of epithelioid granuloma, a collection of macrophages and other inflammatory cells, is a relatively specific histological feature of CD, although it is only seen in fewer than half of CD patients. The aetiology and significance of granuloma in CD remain unclear. Mycobacterium paratuberculosis has been suggested by some observations to be the pathogen related to Crohn's granuloma formation, but this has not been confirmed. On the other hand, limited studies have suggested that granuloma formation is associated with a Th1-shifted immune response, by showing immunohistochemically an increased expression of Th1-type cytokines [IFN-γ, IL-12] and accumulation of CCR5 + and CXCR3 + Th1 cells in colonic mucosa with Crohn's granuloma. 56, 57 In our study, it was surprisingly revealed that the intestinal mucosa with Crohn's granulomas had significantly increased prevalence of IL- The present study is, to out knowledge, the first to systemically analyse the association between the histopathological features and immunological abnormalities in colonic mucosa in IBD. However, there are some limitations to our study. First, it focused on the large intestine only. Some biopsies were randomly taken, not site-specific. Concurrent medications are likely to change the prevalence of CD4 + T cells in lamina propria. All these are confounding factors that should be taken into account in future studies. Second, the immunological study was done by flow cytometry, which although providing more detailed information on immunotypes, was performed on different [but adjacent] pieces of mucosal tissue, instead of by direct immunohistochemical staining on the exact same tissue as that for histological evaluation. Lastly, the possible relationship of certain Th subsets with certain histological changes could only be postulated based on the quantitative correlation analysis.
In conclusion, aberrant adaptive immunity appears to be associated with the patterns of histopathological changes in intestinal mucosa in IBD. Treg cells are associated with the active inflammation, Th22 with chronic crypt architecture alteration, and Th17 with the Paneth cell metaplasia/hyperplasia. These findings are novel and provide further insight into the pathogenesis of IBD.
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